Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Atropine Industry: Supply and Demand, Markets and Prices 2021-2027

Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Atropine Market Status and Forecast (2016-2027)
      • 1.3.2 Global Atropine Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Atropine Supply by Company

    • 2.1 Global Atropine Sales Volume by Company
    • 2.2 Global Atropine Sales Value by Company
    • 2.3 Global Atropine Price by Company
    • 2.4 Atropine Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Atropine Market Status by Category

    • 3.1 Atropine Category Introduction
      • 3.1.1 Injection
      • 3.1.2 Drop
      • 3.1.3 Gel
    • 3.2 Global Atropine Market by Category
      • 3.2.1 Global Atropine Sales Volume by Category (2016-2021)
      • 3.2.2 Global Atropine Sales Value by Category (2016-2021)
      • 3.2.3 Global Atropine Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Atropine Market Status by End User/Segment

    • 4.1 Atropine Segment by End User/Segment
      • 4.1.1 Gastrointestinal
      • 4.1.2 Ophthalmology
      • 4.1.3 Others
    • 4.2 Global Atropine Market by End User/Segment
      • 4.2.1 Global Atropine Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Atropine Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Atropine Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Atropine Market Status by Region

    • 5.1 Global Atropine Market by Region
      • 5.1.1 Global Atropine Sales Volume by Region
      • 5.1.2 Global Atropine Sales Value by Region
    • 5.2 North America Atropine Market Status
    • 5.3 Europe Atropine Market Status
    • 5.4 Asia Pacific Atropine Market Status
    • 5.5 Central & South America Atropine Market Status
    • 5.6 Middle East & Africa Atropine Market Status

    6 North America Atropine Market Status

    • 6.1 North America Atropine Market by Country
      • 6.1.1 North America Atropine Sales Volume by Country (2016-2021)
      • 6.1.2 North America Atropine Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Atropine Market Status

    • 7.1 Europe Atropine Market by Country
      • 7.1.1 Europe Atropine Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Atropine Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Atropine Market Status

    • 8.1 Asia Pacific Atropine Market by Country
      • 8.1.1 Asia Pacific Atropine Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Atropine Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Atropine Market Status

    • 9.1 Central & South America Atropine Market by Country
      • 9.1.1 Central & South America Atropine Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Atropine Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Atropine Market Status

    • 10.1 Middle East & Africa Atropine Market by Country
      • 10.1.1 Middle East & Africa Atropine Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Atropine Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Atropine Distributors
    • 11.3 Atropine Buyers

    12 Global Atropine Market Forecast by Category and by End User/Segment

    • 12.1 Global Atropine Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Atropine Forecast by Category
      • 12.2.1 Global Atropine Sales Volume Forecast by Category
      • 12.2.2 Global Atropine Sales Value Forecast by Category
      • 12.2.3 Global Atropine Price Forecast by Category
    • 12.3 Global Atropine Forecast by End User/Segment
      • 12.3.1 Global Atropine Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Atropine Sales Value Forecast by End User/Segment
      • 12.3.3 Global Atropine Price Forecast by End User/Segment

    13 Global Atropine Market Forecast by Region/Country

    • 13.1 Global Atropine Market Forecast by Region (2022-2027)
      • 13.1.1 Global Atropine Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Atropine Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 C2 PHARMA
      • 14.1.1 Company Information
      • 14.1.2 Atropine Product Introduction
      • 14.1.3 C2 PHARMA Atropine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 RESONANCE LABORATORIES
      • 14.2.1 Company Information
      • 14.2.2 Atropine Product Introduction
      • 14.2.3 RESONANCE LABORATORIES Atropine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Albany Molecular Research
      • 14.3.1 Company Information
      • 14.3.2 Atropine Product Introduction
      • 14.3.3 Albany Molecular Research Atropine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 HENAN PURUI
      • 14.4.1 Company Information
      • 14.4.2 Atropine Product Introduction
      • 14.4.3 HENAN PURUI Atropine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Alchem International
      • 14.5.1 Company Information
      • 14.5.2 Atropine Product Introduction
      • 14.5.3 Alchem International Atropine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 CR Double-Crane
      • 14.6.1 Company Information
      • 14.6.2 Atropine Product Introduction
      • 14.6.3 CR Double-Crane Atropine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Hangzhou Vega
      • 14.7.1 Company Information
      • 14.7.2 Atropine Product Introduction
      • 14.7.3 Hangzhou Vega Atropine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Katsura Chemical
      • 14.8.1 Company Information
      • 14.8.2 Atropine Product Introduction
      • 14.8.3 Katsura Chemical Atropine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 Wuhan senwayer century
      • 14.9.1 Company Information
      • 14.9.2 Atropine Product Introduction
      • 14.9.3 Wuhan senwayer century Atropine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information
    • 14.10 ROLABO OUTSOURCING
      • 14.10.1 Company Information
      • 14.10.2 Atropine Product Introduction
      • 14.10.3 ROLABO OUTSOURCING Atropine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 Contact Information
    • 14.11 Minsheng
    • 14.12 SAURAV CHEMICALS

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Atropine market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Atropine market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Injection
    Drop
    Gel

    Segmented by End User/Segment
    Gastrointestinal
    Ophthalmology
    Others

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    C2 PHARMA
    RESONANCE LABORATORIES
    Albany Molecular Research
    HENAN PURUI
    Alchem International
    CR Double-Crane
    Hangzhou Vega
    Katsura Chemical
    Wuhan senwayer century
    ROLABO OUTSOURCING
    Minsheng
    SAURAV CHEMICALS

    Buy now